Results 91 to 100 of about 9,150,803 (161)

Safety of Adalimumab in Pediatric Patients with Polyarticular Juvenile Idiopathic Arthritis, Enthesitis-Related Arthritis, Psoriasis, and Crohn's Disease [PDF]

open access: yes, 2018
Contains fulltext : 195625.pdf (Publisher’s version ) (Open Access)OBJECTIVE: To evaluate the safety of adalimumab in pediatric patients who participated in clinical trials of juvenile idiopathic arthritis (polyarticular juvenile ...
Arikan, D.   +9 more
core   +1 more source

Outcome of Juvenile Idiopathic Arthritis Associated Uveitis in Two Disease Subtypes

open access: yesThe Turkish Journal of Gastroenterology, 2017
Objectives: This study aims to evaluate the efficacy of adalimumab as a first line biologic agent in specific subtypes of juvenile idiopathic arthritis (JIA) patients with associated uveitis. Patients and Methods: We retrospectively analyzed the data
Dragana LAZAREVIĆ   +3 more
doaj  

Inactive Disease in Enthesitis-related Arthritis: Association of Increased Body Mass Index

open access: yes, 2016
Objective. Patients with enthesitis-related arthritis (ERA) were less likely to achieve and sustain inactive disease than children with other subtypes of juvenile idiopathic arthritis.
Unsal, Erbil   +2 more
core   +1 more source

Axial involvement in enthesitis-related arthritis: results from a single-center cohort. [PDF]

open access: yesPediatr Rheumatol Online J, 2023
Guo Y   +6 more
europepmc   +1 more source

Effectiveness of tumor necrosis factor inhibitors in children with enthesitis-related arthritis: a single-center retrospective analysis. [PDF]

open access: yesFront Pediatr, 2023
Zhang T   +10 more
europepmc   +1 more source

Enthesitis-Related Arthritis in a Child with Turner Syndrome

open access: yesIndian Journal of Rheumatology, 2021
Shruti Bajaj   +2 more
doaj   +1 more source

Counting the cost: the current and future burden of arthritis

open access: yes, 2016
A major new report shows the growing multi-billion dollar costs of arthritis to the economy, individuals and to the healthcare system and how relatively small investments could yield savings of more than $170 million a year.
Arthritis Australia
core  

Leveraging the PEDSnet clinical research network and electronic health record data to enhance efficiency of trial enrollment for a rare pediatric rheumatic disease

open access: yesPediatric Rheumatology Online Journal
Background We evaluated the PEDSnet clinical research network for study enrollment of juvenile spondyloarthritis, a rare rheumatic disease that includes enthesitis-related arthritis (ERA) and psoriatic arthritis (PsA). Methods An electronic health record
Pamela F. Weiss   +12 more
doaj   +1 more source

Secukinumab in enthesitis-related arthritis and juvenile psoriatic arthritis: a randomised, double-blind, placebo-controlled, treatment withdrawal, phase 3 trial. [PDF]

open access: yesAnn Rheum Dis, 2023
Brunner HI   +23 more
europepmc   +1 more source

Synergistic Improvements in Synovitis, Enthesitis, and Patient-Reported Outcomes for Patients with Psoriatic Arthritis Treated with Ixekizumab in SPIRIT Trials

open access: yesRheumatology and Therapy
Introduction Synovitis and enthesitis are key manifestations in psoriatic arthritis (PsA). This descriptive analysis investigated the association between improvement in synovitis and enthesitis, individually and combined, and improvement in patient ...
Lars-Erik Kristensen   +7 more
doaj   +1 more source

Home - About - Disclaimer - Privacy